Biotech Archives - Page 91 of 795

3 minute read

Enveric Biosciences Optimistic On Q4 And Full-Year Results: ‘Psychedelic-Inspired’ Meds For Future Growth

March 27, 8:59 AM

Nasdaq-listed psychedelics biotech Enveric Biosciences (NASDAQ:ENVB) shared its financial results for the fourth quarter of 2023 and the…

ENVB

1 minute read

SciSparc- Clearmind Collaboration Evolves With New International Patent Application For Preventing And Treating Depression

By Benzinga Newsdesk

March 27, 8:56 AM

SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system,

CMND

2 minute read

Protagenic Therapeutics Successfully Concludes Third Cohort In Single Dose Portion Of Phase 1 Trial For Stress-Related Neuropsychiatric Disorders

By Benzinga Newsdesk

March 27, 8:51 AM

Next clinical progress update expected in April 2024NEW YORK, NY / ACCESSWIRE / March 27, 2024 / Protagenic Therapeutics, Inc. (NASDAQ:PTIX), a leader in biopharmaceutical innovation, advances its mission to develop

PTIX

2 minute read

89bio Receives EMA PRIME Status For Pegozafermin In The Treatment Of Metabolic Dysfunction-Associated Steatohepatitis With Fibrosis And Compensated Cirrhosis

By Benzinga Newsdesk

March 27, 8:16 AM

–PRIME status is supported by positive data from the Phase 2b ENLIVEN trial of pegozafermin– –Phase 3 ENLIGHTEN-Fibrosis trial in non-cirrhotic MASH (fibrosis stage F2-F3) patients is enrolling and

ETNB

2 minute read

FSD Pharma Signs Agreement With iNGENu CRO To Conduct A Clinical Study To Assess The Safety And Pharmacokinetics Of Multiple Ascending Doses Of Lucid-21-302 In Healthy Adults

By Benzinga Newsdesk

March 27, 8:12 AM

FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting

CSE:HUGE

3 minute read

Estonia National Biobank Selects PacBio To Sequence 10,000 Whole Genomes

By Happy Mohamed

March 27, 8:10 AM

HiFi Data Generated on the Revio™ System will Support the EU and Estonian Government-Funded Center for Personalized Medicine and Unlock Discoveries Across Cardiology, Mental and Reproductive Health, Drug

PACB

2 minute read

Immuneering Announces First Patient Dosed In Its Phase 1/2a Trial Of IMM-6-415 To Treat Advanced Solid Tumors With RAF Or RAS Mutations

By Happy Mohamed

March 27, 8:08 AM

- Deep Cyclic Inhibitor of the MAPK pathway demonstrated strong tumor growth inhibition in preclinical studies of RAF or RAS mutant tumors, both as monotherapy and in combination - - Phase 1 portion of the Phase 1/2a

IMRX

2 minute read

Aligos Therapeutics Presents Clinical Data At APASL 2024 From ALG-055009 And ALG-000184 Phase 1 Studies

By Happy Mohamed

March 27, 8:06 AM

Aligos Therapeutics, Inc. (NASDAQ:ALGS, ", Aligos", )))), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, today

ALGS

2 minute read

What’s Going On With Stoke Therapeutics Stock Tuesday?

By Adam Eckert

March 26, 4:54 PM

After the market close on Tuesday, Stoke Therapeutics announced a proposed underwritten public offering of up to $75 million of its common stock. The company also intends to grant the underwriters a 30-day window to purchase up to an additional 15% of the shares in the public offering.

STOK